Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DTC Advisory Review Fee To Vary Based On Number Of Expected Submissions

Executive Summary

Under the Prescription Drug User Fee Act agreement between FDA and industry, the level of user fees for advisory review of direct-to-consumer television ads will depend on the number of ads sponsors expect to submit for review during a given year

You may also be interested in...



FDA Begins Reviewing DTC Ads As User Fee Program Faces Pay Or Die Deadline

Industry already has submitted 12 direct-to-consumer television ads to FDA for pre-review through the new DTC user fee program

FDA Begins Reviewing DTC Ads As User Fee Program Faces Pay Or Die Deadline

Industry already has submitted 12 direct-to-consumer television ads to FDA for pre-review through the new DTC user fee program

DTC Review Will Cost Industry $83,000 Per Ad Under FDA’s Final PDUFA Plan

FDA expects to charge companies $83,000 per advertisement under a pre-review program included as part of the agency's proposal for renewal of the prescription drug user fee program

UsernamePublicRestriction

Register

LL1129949

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel